Rhumbline Advisers Green Light Biosciences Holdings, Pbc Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$0.18 - $0.48 $10,784 - $28,759	-59,916 Reduced 87.79%	8,337 $2,000
Q1 2023 May 11, 2023	BUY	$0.34 - $1.19 $265 - $930	782 Added 1.16%	68,253 $29,000
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.0 $22,595 - $43,874	21,937 Added 48.18%	67,471 $80,000
Q3 2022 Nov 10, 2022	BUY	$0.42 - $3.92 $13,647 - $127,372	32,493 Added 249.16%	45,534 $106,000
Q2 2022 Aug 11, 2022	BUY	N/A	13,041 New	13,041 $29,000

51.5K

Ticker GRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 151,460,000
Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.